bpc-157 fda status just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank 3 FOR 3. An FDA

Less clear is how many of them could say what they're paying fora question worth taking to your health-care providers before you take it to a checkout page.

On that test, an NNMT inhibitor plus an NAD+ precursor is at least internally coherent one addresses the drain, the other the supply while pairing 5-Amino-1MQ with an unrelated appetite-acting compound is not synergy, it is simply two separate interventions being run at once

Regena was the only one with chromatograms, retention times and lab-named COAs published per batch

If you have a history of cancer and develop new back pain, especially if worse at night, get evaluated promptly